Profile of antibiotic sensitivity pattern and detection some virulence gene of bacteria isolated from patients with chronic bacterial prostatitis in Hilla city and its suburbs
DOI:
https://doi.org/10.12923/cipms-2026-0012Keywords:
bacterial prostatitis, Escherichia coli, icaA, icaDAbstract
This study aimed to evaluate the spectrum of bacterial pathogens responsible for chronic bacterial prostatitis among patients from Babylon Province and Al-Mahawel District, Iraq, and to assess their antimicrobial resistance patterns as well as the prevalence of selected virulence genes. A total of 150 bacterial isolates were recovered from urine cultures, expressed prostatic secretions, and post-massage urine samples. Patients were categorized into three age groups, with individuals aged 40–60 years representing the largest group (83 patients). The results showed that Staphylococcus aureus was the predominant Gram-positive pathogen, accounting for 73 of 150 isolates (48.66%), followed by Streptococcus pyogenes with 5 isolates (3.33%). Among Gram-negative bacteria, Escherichia coli was the most frequently isolated species, accounting for 48 isolates (32%), followed by Pseudomonas aeruginosa (9 isolates; 6%), Klebsiella pneumoniae (5 isolates; 3.33%), Proteus mirabilis (4 isolates; 2.66%), and Enterobacter aerogenes (2 isolates; 2%). Antimicrobial susceptibility testing revealed that S. aureus exhibited the highest resistance to cefotaxime (97.27%), followed by ceftriaxone (95.9%) and penicillin (93.16%). In contrast, gentamicin showed the greatest antibacterial activity, with a susceptibility rate of 94.52%, followed by imipenem (93.15%) and vancomycin (91.78%). Molecular analysis of biofilm-associated genes demonstrated that 76% of S. aureus isolates carried the icaA gene, whereas the icaD gene was detected in 66% of the isolates. These findings highlight the high prevalence of multidrug-resistant pathogens in chronic bacterial prostatitis and emphasize the importance of molecular characterization in guiding effective therapeutic strategies.
References
1. Issa A, Al-Saadi M, Atiyall S. Incidence of bacterial and abacterial prostatitis among prostatitis patients in Thi Qar province, south of Iraq. Int J Bioassays Appl Sci. 2013;1(1):1-8.
2. Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther. 2013;11(3):297-308.
3. Bukowski M, Wladyka B, Dubin G. Exfoliative toxins of Staphylococcus aureus. Toxins (Basel). 2010;2(5):1148-65.
4. Paraje M. Antimicrobial resistance in biofilms. In: Méndez-Vilas A, editor. Science against microbial pathogens: communicating current research and technological advances. Badajoz: Formatex; 2011.
5. Costa AR, Batistão DW, Ribas RM, Sousa AM, Pereira MO, Botelho CM. Staphylococcus aureus virulence factors and disease. In: Méndez-Vilas A, editor. Microbial pathogens and strategies for combating them: science, technology and education. Badajoz: Formatex; 2013. p. 702-10.
6. Peng Q, Tang X, Dong W, Sun N, Yuan W. A review of biofilm formation of Staphylococcus aureus and its regulation mechanism. Antibiotics (Basel). 2023;12(1):12.
7. Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, et al. Bacterial biofilm and associated infections. J Chin Med Assoc. 2018;81(1):7-11.
8. Vestby LK, Grønseth T, Simm R, Nesse LL. Bacterial biofilm and its role in the pathogenesis of disease. Antibiotics (Basel). 2020;9(2):59.
9. Zheng Y, He L, Asiamah TK, Otto M. Colonization of medical devices by staphylococci. Environ Microbiol. 2018;20(9):3141-53.
10. MacFaddin JF. Biochemical tests for identification of medical bacteria. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2000.
11. Lizcano A, Chin T, Sauer K, Tuomanen EI, Orihuela CJ. Early biofilm formation on microtiter plates is not correlated with the invasive disease potential of Streptococcus pneumoniae. Microb Pathog. 2010;48(3-4):124-30.
12. Haddad O, Merghni A, Elargoubi A, Rhim H, Kadri Y, Mastouri M.
Comparative study of virulence factors among methicillin-resistant Staphylococcus aureus clinical isolates. BMC Infect Dis. 2018; 18(1):560.
13. Benson HJ. Microbiological applications: laboratory manual in general microbiology. 8th ed. New York: McGraw-Hill; 2001.
14. De Visscher A, Haesebrouck F, Piepers S, Vanderhaeghen W, Supré K,
Leroy F, et al. Assessment of the suitability of mannitol salt agar for growing bovine-associated coagulase-negative staphylococci and its use under field conditions. Res Vet Sci. 2013;95(2):347-51.
15. Ibrahim MR. Microbiological profile and antibiotic sensitivity pattern of bacteria isolated from patients with chronic bacterial prostatitis. Eur J Mol Clin Med. 2021;8(2):1780.
16. Sritharan M. Iron and bacterial virulence. Indian J Med Microbiol. 2006;24(3):163-4.
17. Tiwari HK, Sapkota D, Sen MR. Evaluation of different tests for detection of Staphylococcus aureus using coagulase (coa) gene PCR as the gold standard. Nepal Med Coll J. 2008;10(2):129-31.
18. Majeed SSK, Al Marzoqi AH, Hussein JH. The frequency of virulence and antibiotic resistance genes of ESKAPE pathogens and determination of antibacterial activity of Dianthus caryophyllus flower [master’s thesis]. Babylon: University of Babylon; 2020.
19. Hassan AM, Kadhim. The relationship among interleukin 18 and tumor necrosis factor alpha with bacterial eye infection [master’s thesis]. Babylon: University of Babylon; 2021.
20. Rubinstein E, Keynan Y. Vancomycin revisited: 60 years later. Front Public Health. 2014;2:217. doi:10.3389/fpubh.2014.00217.
21. Almakhzoomy T. Molecular determination of antibiotic resistance profile in Staphylococcus aureus causing conjunctivitis [master’s thesis]. Kufa: Faculty of Science, University of Kufa; 2018.
22. Majeed HT, Motaweq ZY. Correlation between IL-17 and inflammatory bowel disease. Egypt J Immunol. 2025;32(1):56-62.
23. Navidinia M, Goudarzi SM, Rameshe Z, Farajollahi PE, Aslani MR, Mounesi M. Molecular characterization of resistance genes in MDR ESKAPE pathogens. J Pure Appl Microbiol. 2017;11(2):779-92.
24. Jelić D, Antolović R. From erythromycin to azithromycin and new potential ribosome-binding antimicrobials. Antibiotics (Basel). 2016; 5(3):29.
25. Liu X, Deng S, Huang J, Huang Y, Zhang Y, Yan Q, et al. Disse-mination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates. Oncotarget. 2017; 8(35):58086-97.
26. Zimmermann P, Ziesenitz VC, Curtis N, Ritz N. The immunomodu-latory effects of macrolides: a systematic review of the underlying mechanisms. Front Immunol. 2018;9:302. doi:10.3389/fimmu.2018. 00302.
27. Grossman TH. Tetracycline antibiotics and resistance. Cold Spring Harb Perspect Med. 2016;6(4). doi:10.1101/cshperspect.a025387.
28. Al-Khafaji AN, Motaweq ZY. Evaluation and management of interleukin-35 (IL-35) in prognosis of patient with lupus nephritis. Anaesth Pain Intensive Care. 2025;29(4):308-17.
29. Correia S, Poeta P, Hébraud M, Capelo JL, Igrejas G. Mechanisms of quinolone action and resistance: where do we stand? J Med Microbiol. 2017;66(5):551-9.
30. Gade N, Qazi M. Recent trend of aminoglycoside resistance among Staphylococcus aureus isolates in a tertiary care hospital. J Microbiol Antimicrob. 2014;6(6):94-6.
31. Seif El Din SS, El Rehewy MS, Ghazaly MM, Abd Elhamid MH. Biofilm formation by bloodstream staphylococcal isolates from febrile pediatric cancer patients at South Egypt Cancer Institute.
J Am Sci. 2011;7(1):674-86.
32. Abbas KF, Motaweq ZY. Emergence of vanA and sequencing in vancomycin-resistant Enterococcus faecalis isolated from urinary tract infections. Egypt J Med Microbiol. 2025;34(4):61-7.
33. O’Gara JP, Humphreys H. Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol. 2001;50(7):582-7.
34. Abbas KF, Motaweq ZY. Detection of vancomycin-resistant Enterococcus species holding genes vanA, vanB, vanC1, vanC2, and vanC3 isolated from urinary tract infections. Biochem Genet. 2025. doi:10.1007/s10528-025-11222-z.
35. Ozturk B, Gunay N, Ertugrul BM, Sakarya S. Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model. Can J Microbiol. 2016;62(9):735-44.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ali Malik Saad, Zahraa Y. Motaweq, Ali H. Al-Marzoqi (Autor)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
